A Five-Year Roadmap for AI-Powered Medical Imaging Analytics

The challenge

A developer of artificial intelligence (AI)-powered medical imaging analytics for early detection of cardiac and bone disease sought to define a go-to-market strategy for the U.S. market with return on investment (ROI) quantification. The client aimed to equip its sales team with evidence-based materials, including clinical use cases for health systems and guidance on optimal product and service bundles.

L.E.K. Consulting was selected for its deep medtech and AI expertise to design a clear, phased strategy that would accelerate adoption and position the client for long-term success.

At a glance, our client:

Needed a structured U.S. go-to-market plan to drive adoption of AI-powered analytics with ROI quantification
Sought to equip the commercial team with targeted sales materials and clinical use cases
Wanted to align near-term commercialization with a scalable, long-term innovation roadmap

Our approach

We developed a five-year go-to-market strategy organized into distinct phases, each designed to build commercial readiness and scale market adoption over time.

Year 1: foundation building

The first year focuses on laying the groundwork — onboarding early adopters, building infrastructure, compiling data and engaging key medical societies to secure buy-in.

Years 2–3: evidence and adoption

The next phase emphasizes generating clinical evidence and accelerating adoption through targeted sales efforts, reimbursement readiness and a physician referral playbook to capture best practices.

Years 4–5: broader adoption and support

These years outline plans to scale adoption across health systems, expand support services and strengthen market credibility through reimbursement preparation.

Beyond Year 5: continuous innovation and scaling

Beyond five years, the roadmap calls for ongoing innovation — expanding features, enhancing services and investing in infrastructure to maintain leadership in AI medical imaging.

Key elements of the approach:

Structured a phased, five-year roadmap with ROI evaluation
Combined AI, clinical and market insights to guide adoption and expansion
Developed tailored sales materials and playbooks to enable execution across teams

The results

Our strategy positioned the AI imaging company for sustained success in the U.S. market. The client received a clear, time-based roadmap detailing market entry, customer targeting and commercialization milestones, supported by tactical sales tools and evidence-building plans.

The roadmap not only prepared the company for near-term launch but also ensured readiness for continuous innovation and scaling beyond the first five years.

Impact delivered:

Provided a five-year strategic roadmap linking clinical, commercial and operational goals
Enabled data-driven market entry supported by tailored sales and evidence tools
Positioned the company for scalable, long-term growth in AI-powered medical imaging